Candel Therapeutics, Inc. - Common Stock (CADL)

CUSIP: 137404109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
54,992,500
Total 13F shares
4,884,284
Share change
+4,072,547
Total reported value
$52,945,000
Price per share
$10.84
Number of holders
12
Value change
+$44,146,000
Number of buys
11

Quarterly Holders Quick Answers

What is CUSIP 137404109?
CUSIP 137404109 identifies CADL - Candel Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Candel Therapeutics, Inc. - Common Stock (CADL) as of Q3 2021

As of 30 Sep 2021, Candel Therapeutics, Inc. - Common Stock (CADL) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,884,284 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, Sands Capital Ventures, LLC, VANGUARD GROUP INC, Woodline Partners LP, CAAS CAPITAL MANAGEMENT LP, STATE STREET CORP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.